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Quality assurance
Substantial discoveries at Kansas State University 
are sparking innovation for the private sector, 
economic growth in the state
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A recent 40 percent increase in patents awarded to Kansas State 
University — and success in licensing this 
technology — shows the university packs a 
powerful one-two punch when it comes to 
discovery and commercialization.
“Kansas State University is quality-
focused,” said Kent Glasscock, president 
of the Kansas State University Institute for 
Commercialization. “We have an outstanding 
system that takes quality disclosures and 
converts them into meaningful partnerships 
with companies that take our inventions into 
the global marketplace.”
The Kansas State University Research 
Foundation and the Kansas State University 
Institute for Commercialization work 
together to help university researchers 
take their ideas and inventions and make 
them profitable. The foundation handles 
researcher disclosures and the patent process, 
and the institute works with companies to 
license the new technology.
According to the foundation’s records, 
the university averages four to six patents 
per year. In 2014, that number rose to 14 
patents — but the actual number of patents 
awarded to university researchers isn’t 
necessarily the focus.
“Kansas State University’s increase 
is noticeable in regard to the number of 
disclosures and patents awarded, but what 
we also are really good at is converting the 
patents we generate into licenses that create 
revenue,” Glasscock said. “We are ranked 
36th in the nation by the Association of 
University Technology Managers for licenses 
and options to license per 100 disclosures.”
The rankings place Kansas State 
University ahead of Harvard University, 
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Duke University, Pennsylvania State University, Johns 
Hopkins University and Purdue University, among 
others, in earning more revenue per licensed patent.
In fiscal year 2014, the institute generated $2.4 
million in university revenue and $3 million in value of 
equity holdings. It also has created 384 jobs in the region 
with salaries averaging $57,200.
As well as fostering industry growth, these successes 
are helping the university with its visionary plan to be a 
Top 50 public research university. The K-State 2025 plan 
includes increasing intellectual capital from research.
“K-State 2025 sets a vision in which Kansas State 
University is a center of innovation and research for 
the state, the nation and the world,” said Jim Guikema, 
Kansas State University Research Foundation president 
and associate vice president for research. “To be effective, 
the product of research has to have value. If you give 
something away freely to everyone, it has no value. If 
you tell a company here is something you can make 
money on and we can do it together, now it has value.”
Three innovations — among many — benefited 
from the Institute for Commercialization and Research 
Foundation partnership in 2014.
New opportunities for 
biomedicine
Xiuzhi “Susan” Sun, university distinguished 
professor of grain science and bio- and agro-engineering, 
and Hongzhou “John” Huang, a 2012 doctoral 
graduate, conducted research that led to U.S. Patent No. 
8,835,395, “Novel Protein Peptide Hydrogels.”
The hydrogels are formed from various combinations 
of short peptides — compounds created from amino 
acids — and may have numerous biomedical research 
uses. They also can be used for medical device 
application, such as scaffolds or artificial extracellular 
matrix for tissue engineering and healing wounds; cell 
therapies; combining with stem cells to repair or replace 
organs; drug delivery; an adjuvant for vaccines; and drug 
and cell encapsulation.
This hydrogel patent is licensed to PepGel LLC. 
The company is an inventor-owned startup and was 
chosen by CIO Review as one of its 20 most promising 
biotechnology solution providers.
Improving livestock health
Jim Drouillard, professor of animal sciences and 
industry; Tom Herald, food chemist and adjunct 
professor of grain science and industry; and Matthew 
Greenquist, former graduate student, conducted research 
that led to U.S. Patent No. 8,828,421, “Method for 
Encapsulation of Orally Ingested Materials to Alter the 
Site of Digestion, Site of Action, or Stability.”
The encapsulation is a candy-like coating — visually 
similar to peanut brittle — that protects vitamins and 
other micronutrients given to cattle and other ruminant 
animals from being prematurely digested by bacteria in 
the animal’s digestive system. Once the material bypasses 
the rumen and ends up in the gastric portion of the 
animal’s stomach, strong acids in the stomach dissolve 
the coating, releasing the nutrient so the animal can 
absorb it.
The patent is licensed to AFGRI Operations Limited, 
part of the South African food group AFGRI. The 
technology is deployed through AFGRI Animal Feeds, 
one of South Africa’s leading animal feed manufacturers.
Safer pest control
Kun Yan Zhu, professor of entomology; Xin Zhang, 
research associate in the Division of Biology; and 
Jianzhen Zhang, visiting scientist from Shanxi University 
in China, conducted research that led to U.S. Patent 
8,841,272, “Double-Stranded RNA-Based Nanoparticles 
for Insect Gene Silencing.”
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By Stephanie Jacques
Double-stranded RNA, or dsRNA, is a microscopic, 
genetics-based technology that can help safely kill 
mosquitos and other insect pests by using a biological 
process known as RNA interference, or RNAi, to 
destroy the genetic code of an insect in a specific DNA 
sequence. The technology can have great potential for 
safe and effective control of insect pests without harming 
unintended species, such as pets.
The Kansas State University Institute for 
Commercialization is working with several companies 
interested in obtaining a license to the patent.
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